Wells Fargo
VRPX

Wells Fargo’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Wells Fargo’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$34 – 7746
2024
Q1 		– Hold
0
– – – 6955
2023
Q4 		– Hold
0
– – – 7210
2023
Q3 		– Hold
0
– – – 6919
2023
Q2 		– Hold
0
– – – 6976
2023
Q1 		– Hold
0
– – – 7129
2022
Q4 		– Hold
0
– – – 7108
2022
Q3 		– Hold
0
– – – 7640
2022
Q2 		– Hold
0
– – – 7752
2022
Q1 		– Hold
0
– – – 8083
2021
Q4 		– Sell
-2
Closed -$2.06K – 8027
2021
Q3 		$3K Buy
+2
New +$4.19K ﹤0.01% 6521
2021
Q2 		– Hold
0
– – – 7644

Other funds holding VRPX

WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SRCM
Signature Resources Capital Management Newport Beach, California $254M AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Wells Fargo's VRPX Position: Q2 2024 in Review

Wells Fargo held its Virpax Pharmaceuticals, Inc. Common Stock (VRPX) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7746.

Wells Fargo first reported a position in VRPX in Q3 2021 and has held it in 1 quarter since. The position peaked at $3K in Q3 2021. 5 funds tracked by Wall St. Rank hold VRPX as of Q2 2024.

  • Wells Fargo held 0 shares of Virpax Pharmaceuticals, Inc. Common Stock worth $0 as of Q2 2024.
  • Wells Fargo left its Virpax Pharmaceuticals, Inc. Common Stock share count unchanged in Q2 2024.
  • Virpax Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Wells Fargo's portfolio in Q2 2024, its #7746 holding.
  • Wells Fargo first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q3 2021 and has held it in 1 quarter since.
  • Wells Fargo's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.